SANTEN PHARMACEUTICAL CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,614 JPY | -0.28% |
|
+5.66% | +14.91% |
Presenter SpeechShigeo Taniuchi (Executives)Good afternoon, ladies and gentlemen. Thank you ve...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and sales of pharmaceutical products. The Company has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The Company engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The Company operates in Japan, Europe, Asia, North America markets.
Sector
Pharmaceuticals
Calendar
25/06/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
1,619
JPY
Average target price
1,827
JPY
Spread / Average Target
+12.85%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +14.91% | 3.75B | |
| +38.59% | 727B | |
| -7.89% | 347B | |
| +15.66% | 319B | |
| +0.24% | 274B | |
| +13.47% | 238B | |
| +7.35% | 204B | |
| -6.42% | 203B | |
| +4.23% | 161B | |
| -1.70% | 160B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Transcript : Santen Pharmaceutical Co., Ltd., Q2 2020 Earnings Call, Nov 07, 2019
